PO-065: SIWA318H是一种晚期糖基化终产物(AGE)靶向抗体，在人源化小鼠胰腺癌异种移植模型中有效

{"title":"PO-065: SIWA318H是一种晚期糖基化终产物(AGE)靶向抗体，在人源化小鼠胰腺癌异种移植模型中有效","authors":"A. Jensen, G. Rossi, R. Muñoz, Kimberly M. Brothers, L. Gruber, Misty S. Gruber, Haiyong Han","doi":"10.1158/1538-7445.panca21-po-065","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":169481,"journal":{"name":"Preclinical Models","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract PO-065: SIWA318H, an advanced glycation end product (AGE) targeting antibody, is efficacious in a humanized mouse xenograft model for pancreatic cancer\",\"authors\":\"A. Jensen, G. Rossi, R. Muñoz, Kimberly M. Brothers, L. Gruber, Misty S. Gruber, Haiyong Han\",\"doi\":\"10.1158/1538-7445.panca21-po-065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":169481,\"journal\":{\"name\":\"Preclinical Models\",\"volume\":\"14 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Preclinical Models\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.panca21-po-065\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Preclinical Models","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.panca21-po-065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}